Related Experiment Video
Updated: Feb 10, 2026

Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells
Published on: December 29, 2012
A halogen bond-mediated highly active artificial chloride channel with high anticancer activity
Changliang Ren1, Xin Ding1, Arundhati Roy1
1Institute of Bioengineering and Nanotechnology , 31 Biopolis Way, The Nanos , Singapore 138669 .
Researchers developed a novel artificial chloride channel using a simple peptide scaffold. This new channel shows high activity and selectivity, demonstrating potential for cancer treatment by effectively inhibiting cancer cell growth.
Area of Science:
- Supramolecular chemistry
- Membrane biophysics
- Medicinal chemistry
Background:
- Chloride channels are crucial for cellular functions and disease treatment, but existing artificial channels have limitations.
- Current artificial anion channels suffer from poor activity, low selectivity, and lack of structural modifiability.
- Limited research exists on artificial chloride channels compared to chloride carriers.
Purpose of the Study:
- To design and synthesize a novel, modular artificial anion channel scaffold.
- To investigate the potential of halogen bond-mediated assembly for creating transmembrane pathways.
- To evaluate the anticancer activity of the developed chloride channel.
Main Methods:
- Utilized a monopeptide-based scaffold for constructing halogen bond-mediated artificial anion channels.
- Employed directional assembly of electron-deficient iodine atoms to form transmembrane pathways.
- Optimized channel activity and selectivity through combinatorial modification of the scaffold backbone.
- Assessed the inhibitory concentration 50 (IC50) against human breast cancer cells (BT-474).
Main Results:
- Successfully constructed a robust and accessible artificial anion channel system.
- Developed a highly active chloride channel, designated A10, with enhanced transport properties.
- Achieved significant inhibition of human breast cancer cell growth with an IC50 of 20 μM.
- Demonstrated superior anticancer activity compared to cisplatin.
Conclusions:
- The novel monopeptide scaffold provides a versatile platform for creating artificial anion channels.
- The developed chloride channel A10 exhibits potent anticancer activity, suggesting therapeutic potential.
- This work opens new avenues for designing artificial ion channels for biomedical applications.
Related Concept Videos
Halogens
IR Spectrum Peak Intensity: Amount of IR-Active Bonds
Bond Dissociation Energy and Activation Energy
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Activation Energy
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...

